Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Is a |
Product containing bromazine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Is a |
Codeine-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sederende antihistamin |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Morphinan opioid |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bromazine |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine (substance) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Is a |
Product containing bromazine and codeine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Has manufactured dose form |
Conventional release oral syrup (dose form) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cardiovascular agent (substance) |
false |
Inferred relationship |
Some |
|
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|